¹⁷⁷Lutetium PSMA radioligand therapy for the treatment of metastatic castrate-resistant prostate cancer: Evidence synthesis to support a generic justification decision
Health Information and Quality Authority
Record ID 32018012820
English
Details
Project Status:
Completed
URL for project:
https://www.hiqa.ie/reports-and-publications/health-technology-assessment/177lutetium-psma-radioligand-therapy
Year Published:
2024
URL for published report:
https://www.hiqa.ie/sites/default/files/2024-04/2023-004-Report.pdf
URL for additional information:
https://www.hiqa.ie/reports-and-publications/health-technology-assessment/177lutetium-psma-radioligand-therapy
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Ireland
MeSH Terms
- Lutetium
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- Radiopharmaceuticals
Keywords
- 177Lu-PSMA
Contact
Organisation Name:
Health Information and Quality Authority (HIQA)
Contact Address:
Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name:
info@hiqa.ie
Contact Email:
info@hiqa.ie
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.